Updated Results from Phase 2 Study of Guadecitabine for Patients with Untreated INT-2/High Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Saved in:
Bibliographic Details
Published in:Leukemia research 2017-04, Vol.55, p.S25-S26
Main Authors: Montalban-Bravo, G, Prithviraj, B, Alvarado, Y, Daver, N, Ravandi, F, Borthakur, G, Takahashi, K, Andreeff, M, Cortes, J, DiNardo, C, Jabbour, E, Kadia, T, Kornblau, S, Ohanian, M, Nogueras-Gonzalez, G.M, Bodden, K, Pierce, S, Kantarjian, H, Garcia-Manero, G
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0145-2126
DOI:10.1016/S0145-2126(17)30152-2